Experiment 411313

Worktypes

PHARMACOKINETIC/BIOAVAILABITY STUDYPHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

AESCIN,BETA:

Details

PropertyValue
Pharmacology
TOXICITY ASSESSMENT(QUANTITATIVE)
Administration routeORAL
OrganismEmpty organism
CitationEISENBURGER,R: HOFRICHTER,G: LEIHN,HD: LUDWIG,E:. (1976). PHARMACODYNAMICS OF ALPHA-AND BETA-ESCIN AFTER ORAL APPLICATION.. 26()
Amount utilized
Compound isolated
Dose amount400.0 MG
Number5
Qualitative result.
AnimalRAT
Per unitKG
Dose expressionLD50